Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Novartis
Johnson and Johnson
Fish and Richardson
Colorcon
Chinese Patent Office
McKinsey
AstraZeneca
Harvard Business School

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065111

« Back to Dashboard

NDA 065111 describes KANAMYCIN SULFATE, which is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Loch, Pharmafair, Solopak, Warner Chilcott, and Watson Labs, and is included in twelve NDAs. It is available from one supplier. Additional details are available on the KANAMYCIN SULFATE profile page.

The generic ingredient in KANAMYCIN SULFATE is kanamycin sulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for 065111
Tradename:KANAMYCIN SULFATE
Applicant:Fresenius Kabi Usa
Ingredient:kanamycin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 065111
Suppliers and Packaging for NDA: 065111
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 065111 ANDA Fresenius Kabi USA, LLC 63323-359 N 63323-359-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/2ML
Approval Date:Dec 17, 2002TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/3ML
Approval Date:Dec 17, 2002TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Dow
US Army
QuintilesIMS
Accenture
McKinsey
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot